These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28682227)

  • 21. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.
    Zitvogel L; Ma Y; Raoult D; Kroemer G; Gajewski TF
    Science; 2018 Mar; 359(6382):1366-1370. PubMed ID: 29567708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota, obesity and diabetes.
    Patterson E; Ryan PM; Cryan JF; Dinan TG; Ross RP; Fitzgerald GF; Stanton C
    Postgrad Med J; 2016 May; 92(1087):286-300. PubMed ID: 26912499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
    Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
    Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can gut microbes play a role in mental disorders and their treatment?
    Latalova K; Hajda M; Prasko J
    Psychiatr Danub; 2017 Mar; 29(1):28-30. PubMed ID: 28291971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
    Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
    Front Immunol; 2019; 10():2989. PubMed ID: 32010123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications.
    Valsecchi AA; Ferrari G; Paratore C; Dionisio R; Vignani F; Sperone P; Vellani G; Novello S; Di Maio M
    Crit Rev Oncol Hematol; 2024 May; 197():104328. PubMed ID: 38490281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
    Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor.
    Liu R; Wang J; Liu Y; Gao Y; Yang R
    Cancer Lett; 2024 Aug; 598():217115. PubMed ID: 39025428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review.
    Szczyrek M; Bitkowska P; Chunowski P; Czuchryta P; Krawczyk P; Milanowski J
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
    Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
    Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder.
    Li Q; Zhou JM
    Neuroscience; 2016 Jun; 324():131-9. PubMed ID: 26964681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Bugs a NOD Away from Improving Cancer Therapy Efficacy.
    Araya RE; Goldszmid RS
    Immunity; 2016 Oct; 45(4):714-716. PubMed ID: 27760335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations.
    Parchment RE; Voth AR; Doroshow JH; Berzofsky JA
    Semin Oncol; 2016 Aug; 43(4):501-13. PubMed ID: 27663482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting gut microbiome: A novel and potential therapy for autism.
    Yang Y; Tian J; Yang B
    Life Sci; 2018 Feb; 194():111-119. PubMed ID: 29277311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tackling probiotic and gut microbiota functionality through proteomics.
    Ruiz L; Hidalgo C; Blanco-Míguez A; Lourenço A; Sánchez B; Margolles A
    J Proteomics; 2016 Sep; 147():28-39. PubMed ID: 27003613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.